Nettacin (Netilmicin)

Netilmicin, the active ingredient in Nettacin, is an aminoglycoside antibiotic presented as an ophthalmic solution for ocular use. It is employed to treat bacterial conjunctivitis and other bacterial eye infections in patients requiring topical antimicrobial therapy. The drug works by inhibiting bacterial protein synthesis, leading to rapid bacterial cell death and resolution of infection.

GNH USA supplies Nettacin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, eye‑care centres and clinics worldwide, with consistent quality and regulatory compliance.

Netilmicin is used to treat bacterial ocular infections by targeting susceptible Gram‑positive and Gram‑negative organisms.

- Bacterial conjunctivitis: reduces bacterial load and alleviates redness, discharge and irritation. - Bacterial keratitis: eradicates causative pathogens to promote corneal healing. - Post‑operative ocular infection: prevents or treats infection following eye surgery.

Adverse ocular reactions may occur with Nettacin use.

Common Side Effects: - Eye irritation: mild burning or stinging upon instillation. - Redness: transient conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign body sensation: feeling of grit in the eye. - Blurred vision: temporary visual disturbance after dosing. - Eyelid swelling: mild peri‑ocular edema.

Serious or Rare Side Effects: - Allergic reaction: swelling, rash or severe itching of the eye. - Corneal ulceration: progressive loss of corneal tissue. - Severe eye pain: intense discomfort indicating possible toxicity. - Vision loss: rare but may occur with extensive corneal damage. - Systemic nephrotoxicity: renal impairment if significant systemic absorption. - Ototoxicity: hearing impairment in rare systemic exposure cases.

Before prescribing Nettacin, consider the following precautions.

- Hypersensitivity assessment: verify no known allergy to aminoglycosides or Netilmicin. - Indication confirmation: use only for confirmed bacterial eye infections. - Contact lens use: advise patients to remove lenses during treatment. - Renal monitoring: consider renal function in prolonged therapy due to possible systemic absorption. - Concomitant ototoxic drugs: avoid use with other ototoxic agents if systemic exposure is possible. - Store at room temperature: keep in original container, protect from light and moisture.

Nettacin may interact with other medicines; consider the following.

Major Interactions (Avoid): - Systemic aminoglycosides: additive nephro‑ and ototoxicity risk. - Loop diuretics: increased risk of renal toxicity. - Neuromuscular blocking agents: enhanced neuromuscular blockade.

Moderate Interactions (Monitor Closely): - Topical ophthalmic steroids: may mask infection signs. - Non‑steroidal anti‑inflammatory eye drops: potential for increased ocular irritation. - Other ototoxic drugs: monitor for systemic absorption‑related toxicity.